Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
MASS
HOLD908 Devices Inc. · Healthcare · United States · $293M · Avg Vol: $2M/d
COMPANY DESCRIPTION
908 Devices Inc. develops and commercializes compact, handheld, and desktop mass spectrometry devices for rapid chemical and biochemical analysis across life science research and security markets. The company's competitive moat is based on its proprietary miniaturized mass spectrometry technology, offering unparalleled portability and ease of use compared to traditional laboratory instruments. 908 Devices is a disruptive innovator, democratizing access to advanced analytical capabilities for critical field and lab-based applications.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 46.9M | 50.2M | 47.7M | 56.2M | 6.2% | 57.8M | 68.6M | 82.4M | 21.1% |
| EPS | -1.07 | -1.13 | -2.12 | 0.54 | — | -0.93 | — | — | — |
| Shares | 31.9M | 32.5M | 35.1M | 36.3M | +14.0% | 41.0M | — | — | — |
| Debt | 19.5M | 5.9M | 4.1M | 4.6M | -38.1% | 4.5M | — | — | — |
| Equity | 190.6M | 165.5M | 114.6M | 143.7M | -9.0% | — | — | — | — |
| Op CF | -20.9M | -25.1M | -30.2M | -23.7M | — | -7.5M | — | — | — |
| Inv CF | -15.8M | -26.4M | -46.3M | 50.7M | — | — | — | — | — |
| Fin CF | 1.2M | -15.9M | -0.4M | -0.7M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MASS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| MASS | 908 Devices Inc.(you) | $293M | 52 | HOLD |
| OFIX | Orthofix Medical Inc. | $455M | 51 | HOLD |
| KIDS | OrthoPediatrics Corp. | $485M | 50 | HOLD |
| VREX | Varex Imaging Corporation | $460M | 56 | HOLD |
| INGN | Inogen, Inc. | $167M | 55 | HOLD |
| CERS | Cerus Corporation | $587M | 46 | HOLD |
| TMCI | Treace Medical Concepts, Inc. | $259M | 33 | SELL |
| CTKB | Cytek Biosciences, Inc. | $576M | 40 | HOLD |
| APYX | Apyx Medical Corporation | $165M | 36 | HOLD |
| SIBN | SI-BONE, Inc. | $737M | 42 | HOLD |
Peer medians: ROE -25.6% · P/E 27.7x · Gross margin 50.5%